AI-generated summary
The authors report a double-blind, placebo-controlled randomized trial of 635 nm low-level laser therapy on chronic venous leg ulcers over 12 weeks. Complete wound closure and ulcer size did not differ significantly between the laser and placebo groups, while pain scores fell in both groups. The authors suggest possible delayed effects that would need further study.
- Participants
- 24
- Who or what was studied
- Patients with chronic venous leg ulcers, 5 to 20 cm2, with a 6-week history and venous origin confirmed by Doppler ultrasound and an ankle brachial index of 0.8 or greater
- Wavelengths
- 635 nm
- Limits stated in the abstract
- The authors state that the trial's limitations mean LLLT may not have early effects, and the small sample of 24 patients limits the strength of conclusions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 635 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Placebo-controlled, Randomized controlled trial, Wound healing. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.